These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8777683)

  • 1. Screening for tyrosinaemia type I.
    Hutchesson AC; Hall SK; Preece MA; Green A
    Arch Dis Child Fetal Neonatal Ed; 1996 May; 74(3):F191-4. PubMed ID: 8777683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of disease and gene frequencies of inborn errors of metabolism among different ethnic groups in the West Midlands, UK.
    Hutchesson AC; Bundey S; Preece MA; Hall SK; Green A
    J Med Genet; 1998 May; 35(5):366-70. PubMed ID: 9610798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal screen for hereditary tyrosinaemia type I.
    Holme E; Lindstedt S
    Lancet; 1992 Oct; 340(8823):850. PubMed ID: 1357267
    [No Abstract]   [Full Text] [Related]  

  • 4. Tyrosinaemia and tyrosyluria in infancy.
    Wong PW; Lambert AM; Komrower GM
    Dev Med Child Neurol; 1967 Oct; 9(5):551-62. PubMed ID: 6066020
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of a nation-wide neonatal metabolic screening programme in Sweden 1965-1979.
    Alm J; Larsson A
    Acta Paediatr Scand; 1981 Sep; 70(5):601-7. PubMed ID: 7324907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for several amino acidopathies in neonates in Birmingham by plasma chromatography.
    Raine DN
    Arch Dis Child; 1971 Dec; 46(250):881. PubMed ID: 5129201
    [No Abstract]   [Full Text] [Related]  

  • 7. Health economic analysis of the Swedish neonatal metabolic screening programme. A method of optimizing routines.
    Alm J; Larsson A; Rosenqvist U
    Med Decis Making; 1982; 2(1):33-45. PubMed ID: 6820461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver transplantation in two children with tyrosinaemia type I: biochemical aspects.
    Riudor E; Ribes A; Lloret J; Friden J; Holme E; Jakobs C; Martinez Ibanez V
    J Inherit Metab Dis; 1991; 14(3):281-4. PubMed ID: 1770775
    [No Abstract]   [Full Text] [Related]  

  • 9. Outcome in tyrosinaemia type II.
    Barr DG; Kirk JM; Laing SC
    Arch Dis Child; 1991 Oct; 66(10):1249-50. PubMed ID: 1953015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma amino acid disturbance in infancy. I: Hypermethioninaemia and transient tyrosinaemia.
    Komrower GM; Robins AJ
    Arch Dis Child; 1969 Jun; 44(235):418-21. PubMed ID: 5785193
    [No Abstract]   [Full Text] [Related]  

  • 11. Neonatal screening for inborn errors of metabolism: cost, yield and outcome.
    Pollitt RJ; Green A; McCabe CJ; Booth A; Cooper NJ; Leonard JV; Nicholl J; Nicholson P; Tunaley JR; Virdi NK
    Health Technol Assess; 1997; 1(7):i-iv, 1-202. PubMed ID: 9483160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient neonatal tyrosinaemia.
    Rice DN; Houston IB; Lyon IC; Macarthur BA; Mullins PR; Veale AM; Guthrie R
    J Inherit Metab Dis; 1989; 12(1):13-22. PubMed ID: 2501578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Richner-Hanhart syndrome (oculocutaneous tyrosinaemia, tyrosinaemia type II).
    Paige DG; Clayton P; Bowron A; Harper JI
    J R Soc Med; 1992 Dec; 85(12):759-60. PubMed ID: 1362969
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnostic challenges of aminoacidopathies and organic acidemias in a developing country: a twelve-year experience.
    Karam PE; Habbal MZ; Mikati MA; Zaatari GE; Cortas NK; Daher RT
    Clin Biochem; 2013 Dec; 46(18):1787-92. PubMed ID: 23994778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follow-up study of 16 years neonatal screening for inborn errors of metabolism in West Germany.
    Mathias D; Bickel H
    Eur J Pediatr; 1986 Sep; 145(4):310-2. PubMed ID: 3770001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expanded newborn screening in the Region of Murcia, Spain. Three-years experience].
    Juan-Fita MJ; Egea-Mellado JM; González-Gallego I; Moya-Quiles MR; Fernández-Sánchez A
    Med Clin (Barc); 2012 Dec; 139(13):566-71. PubMed ID: 22137990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic imaging with computed tomography of chronic tyrosinaemia type 1.
    Macvicar D; Dicks-Mireaux C; Leonard JV; Wight DG
    Br J Radiol; 1990 Aug; 63(752):605-8. PubMed ID: 2400875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of tyrosinaemia type III.
    Ellaway CJ; Holme E; Standing S; Preece MA; Green A; Ploechl E; Ugarte M; Trefz FK; Leonard JV
    J Inherit Metab Dis; 2001 Dec; 24(8):824-32. PubMed ID: 11916315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for inherited metabolic disease by plasma chromatography (Scriver) in a large city.
    Raine DN; Cooke JR; Andrews WA; Mahon DF
    Br Med J; 1972 Jul; 3(5817):7-13. PubMed ID: 5039582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence of inherited metabolic disorders in the West Midlands, UK.
    Sanderson S; Green A; Preece MA; Burton H
    Arch Dis Child; 2006 Nov; 91(11):896-9. PubMed ID: 16690699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.